Tejnaksh Healthcare マネジメント

マネジメント基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Ashish Rawandale-Patil

最高経営責任者

₹600.0k

報酬総額

CEO給与比率	100.0%
CEO在任期間	9.7yrs
CEOの所有権	38.3%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	9.8yrs

経営陣の近況

Recent updates

CEO報酬分析

Tejnaksh Healthcare の収益と比較して、Ashish Rawandale-Patil の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	₹22m
Jun 30 2024	n/a	n/a	₹22m
Mar 31 2024	₹600k	₹600k	₹18m
Dec 31 2023	n/a	n/a	₹13m
Sep 30 2023	n/a	n/a	₹10m
Jun 30 2023	n/a	n/a	₹13m
Mar 31 2023	₹500k	₹500k	₹17m
Dec 31 2022	n/a	n/a	₹22m
Sep 30 2022	n/a	n/a	₹26m
Jun 30 2022	n/a	n/a	₹25m
Mar 31 2022	₹300k	₹300k	₹27m
Dec 31 2021	n/a	n/a	₹30m
Sep 30 2021	n/a	n/a	₹29m
Jun 30 2021	n/a	n/a	₹27m
Mar 31 2021	₹700k	₹700k	₹21m
Dec 31 2020	n/a	n/a	₹12m
Sep 30 2020	n/a	n/a	₹12m
Jun 30 2020	n/a	n/a	₹14m
Mar 31 2020	₹2m	₹2m	₹21m
Dec 31 2019	n/a	n/a	₹34m
Sep 30 2019	n/a	n/a	₹34m
Jun 30 2019	n/a	n/a	₹32m
Mar 31 2019	₹1m	₹1m	₹30m
Dec 31 2018	n/a	n/a	₹25m
Sep 30 2018	n/a	n/a	₹26m
Jun 30 2018	n/a	n/a	₹27m
Mar 31 2018	₹878k	₹878k	₹29m

報酬と市場: Ashishの総報酬 ($USD 7.11K ) は、 Indian市場 ($USD 42.63K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Ashishの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Ashish Rawandale-Patil (53 yo)

9.7yrs

在職期間

₹600,000

報酬

Dr. Ashish Vishwas Rawandale-Patil has been Managing Director of Tejnaksh Healthcare Limited since March 19, 2015 and serves as its Chairman. Dr. Rawandale-Patil has been Director at Tejnaksh Healthcare Li...

取締役

名称	ポジション	在職期間	報酬	所有権
Ashish Rawandale-Patil	Chairman & MD	16.8yrs	₹600.00k	38.3% ₹ 182.1m
Preeti Rawandale	Non Executive Non Independent Director	16.8yrs	₹600.00k	35.53% ₹ 168.9m
Kiran Pawar	Non-Executive Independent Director	9.8yrs	データなし	データなし
Vikramsingh Satish Patil	Non-Executive Independent Director	9.8yrs	データなし	データなし
Sanjay Khatal	Non-Executive Non Independent Director	4.3yrs	データなし	データなし
Suhas Thorat	Additional Non-Executive Independent Director	3.3yrs	データなし	データなし

9.8yrs

平均在職期間

52yo

平均年齢

経験豊富なボード: 539428の取締役会は経験豊富であると考えられます ( 9.8年の平均在任期間)。

Tejnaksh Healthcare マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2024

Insufficient new directors

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 21, 2023

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2022

Recent updates

Second quarter 2025 earnings released: EPS: ₹0.31 (vs ₹0.28 in 2Q 2024)

Tejnaksh Healthcare Limited to Report Q2, 2025 Results on Nov 14, 2024

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2024

Insufficient new directors

First quarter 2025 earnings released: EPS: ₹0.29 (vs ₹0.08 in 1Q 2024)

Tejnaksh Healthcare Limited to Report Q1, 2025 Results on Aug 14, 2024

Investor sentiment improves as stock rises 19%

Full year 2024 earnings released: EPS: ₹0.87 (vs ₹0.83 in FY 2023)

Investor sentiment improves as stock rises 16%

Tejnaksh Healthcare Limited to Report Q4, 2024 Results on May 28, 2024

Third quarter 2024 earnings released: EPS: ₹0.27 (vs ₹0.15 in 3Q 2023)

Tejnaksh Healthcare Limited to Report Q3, 2024 Results on Feb 12, 2024

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: ₹0.28 (vs ₹0.41 in 2Q 2023)

Tejnaksh Healthcare Limited to Report Q2, 2024 Results on Nov 11, 2023

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 21, 2023

First quarter 2024 earnings released

Tejnaksh Healthcare Limited to Report Q1, 2024 Results on Aug 12, 2023

Investor sentiment improves as stock rises 111%

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: ₹1.66 (vs ₹2.68 in FY 2022)

Investor sentiment deteriorates as stock falls 15%

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 15%

Third quarter 2023 earnings released: EPS: ₹0.31 (vs ₹0.67 in 3Q 2022)

Tejnaksh Healthcare Limited to Report Q3, 2023 Results on Feb 11, 2023

Tejnaksh Healthcare Limited Launches Product Catheter Caresimulator

Tejnaksh Healthcare Limited Launches New Product Andro-Sim

Second quarter 2023 earnings released: EPS: ₹0.82 (vs ₹0.73 in 2Q 2022)

Tejnaksh Healthcare Limited Innovates PCNL Simulator and changed the practice of PCNL training

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2022

First quarter 2023 earnings released: EPS: ₹0.55 (vs ₹0.75 in 1Q 2022)

Investor sentiment improved over the past week

Tejnaksh Healthcare Limited to Report Q4, 2022 Results on May 17, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹0.73 (vs ₹0.57 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS ₹0.75

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹2.02 (vs ₹2.06 in FY 2020)

Investor sentiment improved over the past week

Non-Executive Independent Director Pratap Patil has left the company

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹0.60 (vs ₹0.58 in 3Q 2020)

New 90-day high: ₹61.05

Tejnaksh Healthcare Limited to Report Q3, 2021 Results on Feb 13, 2021

Investor sentiment improved over the past week

New 90-day high: ₹54.40

Investor sentiment improved over the past week

Market bids up stock over the past week

New 90-day high: ₹42.30

Tejnaksh Healthcare Limited to Report Q2, 2021 Results on Nov 13, 2020

Tejnaksh Healthcare Limited to Report Q1, 2021 Results on Sep 15, 2020

Tejnaksh Healthcare Limited Provides Financial Guidance for the Financial Year 2020-21

New 90-day low - ₹38.00

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

取締役

平均在職期間

平均年齢

マネジメント基準チェック /34